Dermapharm Holding SE 0A5J.IL Stock
Dermapharm Holding SE Price Chart
Dermapharm Holding SE 0A5J.IL Financial and Trading Overview
| Dermapharm Holding SE stock price | 33.51 EUR |
| Previous Close | 46.98 EUR |
| Open | 47.28 EUR |
| Bid | 42.28 EUR x N/A |
| Ask | 52 EUR x N/A |
| Day's Range | 47.28 - 47.28 EUR |
| 52 Week Range | 34.4 - 59.6 EUR |
| Volume | 207 EUR |
| Avg. Volume | 14.71K EUR |
| Market Cap | 2.55B EUR |
| Beta (5Y Monthly) | 1.17203 |
| PE Ratio (TTM) | 14.458715 |
| EPS (TTM) | 2.28 EUR |
| Forward Dividend & Yield | 1.05 (2.22%) |
| Ex-Dividend Date | June 15, 2023 |
| 1y Target Est | N/A |
0A5J.IL Valuation Measures
| Enterprise Value | 3.48B EUR |
| Trailing P/E | 14.458715 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.2573142 |
| Price/Book (mrq) | 4.3846793 |
| Enterprise Value/Revenue | 3.084 |
| Enterprise Value/EBITDA | 10.737 |
Trading Information
Dermapharm Holding SE Stock Price History
| Beta (5Y Monthly) | 1.17203 |
| 52-Week Change | 5.95% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 59.6 EUR |
| 52 Week Low | 34.4 EUR |
| 50-Day Moving Average | 44.56 EUR |
| 200-Day Moving Average | 40.7 EUR |
0A5J.IL Share Statistics
| Avg. Volume (3 month) | 14.71K EUR |
| Avg. Daily Volume (10-Days) | 9.81K EUR |
| Shares Outstanding | 53.84M |
| Float | 17.39M |
| Short Ratio | N/A |
| % Held by Insiders | 67.70% |
| % Held by Institutions | 16.98% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.05 |
| Trailing Annual Dividend Yield | 2.23% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.6636 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 12.97% |
| Operating Margin (ttm) | 26.75% |
| Gross Margin | 63.35% |
| EBITDA Margin | 28.72% |
Management Effectiveness
| Return on Assets (ttm) | 10.39% |
| Return on Equity (ttm) | 25.87% |
Income Statement
| Revenue (ttm) | 1.13B EUR |
| Revenue Per Share (ttm) | 20.99 EUR |
| Quarterly Revenue Growth (yoy) | 37.00% |
| Gross Profit (ttm) | 648.7M EUR |
| EBITDA | 323.91M EUR |
| Net Income Avi to Common (ttm) | 146.27M EUR |
| Diluted EPS (ttm) | 3.27 |
| Quarterly Earnings Growth (yoy) | 32.20% |
Balance Sheet
| Total Cash (mrq) | 213.15M EUR |
| Total Cash Per Share (mrq) | 3.96 EUR |
| Total Debt (mrq) | 1.14B EUR |
| Total Debt/Equity (mrq) | 195.53 EUR |
| Current Ratio (mrq) | 2.297 |
| Book Value Per Share (mrq) | 10.783 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 322.9M EUR |
| Levered Free Cash Flow (ttm) | 220.62M EUR |
Profile of Dermapharm Holding SE
| Country | United Kingdom |
| State | N/A |
| City | Grünwald |
| Address | Lil-Dagover-Ring 7 |
| ZIP | 82031 |
| Phone | 49 89 6 41 86 0 |
| Website | https://www.dermapharm.de |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 2563 |
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription healthcare products, herbal extracts, and other pharmaceutical products. It offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. The company also provides medical devices under the bite away and Herpotherm names. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.
Q&A For Dermapharm Holding SE Stock
What is a current 0A5J.IL stock price?
Dermapharm Holding SE 0A5J.IL stock price today per share is 33.51 EUR.
How to purchase Dermapharm Holding SE stock?
You can buy 0A5J.IL shares on the IOB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Dermapharm Holding SE?
The stock symbol or ticker of Dermapharm Holding SE is 0A5J.IL.
Which industry does the Dermapharm Holding SE company belong to?
The Dermapharm Holding SE industry is Drug Manufacturers-Specialty & Generic.
How many shares does Dermapharm Holding SE have in circulation?
The max supply of Dermapharm Holding SE shares is 55.11M.
What is Dermapharm Holding SE Price to Earnings Ratio (PE Ratio)?
Dermapharm Holding SE PE Ratio is 14.69592100 now.
What was Dermapharm Holding SE earnings per share over the trailing 12 months (TTM)?
Dermapharm Holding SE EPS is 2.28 EUR over the trailing 12 months.
Which sector does the Dermapharm Holding SE company belong to?
The Dermapharm Holding SE sector is Healthcare.